[Other] Ibrutinib Added to Standard Conditioning and As Consolidation Therapy Following Autologous Hematopoietic Stem Cell Transplantation (AutoHCT) for Relapsed/Refractory Activated-B-Cell Subtype Diffuse Large B-Cell Lymphoma (ABC-DLBCL): Prim...

Closed

ThanhNguyen Post time 2024-4-28 17:45:46 | Show all posts |Read mode

Reward10points

tạp chí: Blood

Tác giả: Charalambos Andreadis; Olivia Bobek; Eric D. Hsi; Timothy S. Fenske; Susan M. Geyer; Patrick J. Cứng nhắc; Brian T. Hill; Mitchell Horwitz; Farhad Khimani; Richard F. Little; Bữa tối Shira N.; Jonathan W. Friedberg; Brad S. Kahl; Miguel-Angel Perales; Steven M. Devine; John P. Leonard; Nancy L. Bartlett

Ngày xuất bản: 2023-11-28

DOI: 10.1182/blood-2023-173742

Liên kết PDF: https://ashpublications.org/bloo ... 84/Ibrutinib-Added- to-Standard-Conditioning-and-As

Liên kết bài viết: http://dx.doi.org/10.1182/blood-2023-173742

Nguồn bài viết: Hiệp hội Huyết học Hoa Kỳ。

Nhận xét:

[Other] Ibrutinib Added to Standard Conditioning and As Consolidation Therapy Following Autologous Hematopoietic Stem Cell Transplantation (AutoHCT) for Relapsed/Refractory Activated-B-Cell Subtype Diffuse Large B-Cell Lymphoma (ABC-DLBCL): Prim...

Reply

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Ibrutinib Added to Standard Conditioning and As Consolidation Therapy Following Autologous Hematopoietic Stem Cell Transplantation (AutoHCT) for Relapsed/Refractory Activated-B-Cell Subtype Diffuse Large B-Cell Lymphoma (ABC-DLBCL): Prim... Copy

Reply

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Ibrutinib Added to Standard Conditioning and As Consolidation Therapy Following Autologous Hematopoietic Stem Cell Transplantation (AutoHCT) for Relapsed/Refractory Activated-B-Cell Subtype Diffuse Large B-Cell Lymphoma (ABC-DLBCL): Prim...